Lipochroman-6 as no-synthase inhibitor and uses
AssigneeL’oréAl
InventorsMarie-Madeleine Cals-Grierson, Pascale Pelletier
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of an efficient amount of lipochroman-6, in a physiologically acceptable medium, in a composition or for preparing a composition, the lipochroman-6 or the composition being designed to inhibit NO-synthase.
Claims23
The use of an effective amount of lipochroman-6, in a physiologically acceptable medium, in a composition or for preparing a composition, the lipochroman-6 or the composition being intended to inhibit NO-synthase.
The use as claimed in the preceding claim, characterized in that the lipochroman-6 or the composition is intended to slow down or even inhibit cellular differentiation and/or proliferation.
The use as claimed in the preceding claim, characterized in that the lipochroman-6 or the composition is intended to slow down or even inhibit growth of the epidermis and/or to treat hyperproliferative disorders.
The use as claimed in any one of the preceding claims, characterized in that the lipochroman-6 is in an amount representing from 10−4% to 20% of the total weight of the composition.
The use as claimed in the preceding claim, characterized in that the lipochroman-6 is in an amount representing from 5×10−3% to 10% of the total weight of the composition.
A method of cosmetic treatment for the purpose of treating disorders related to NO synthesis, characterized in that a cosmetic composition comprising at least lipochroman-6, in a physiologically acceptable medium, is used by application to the skin, to the hair and/or to the mucous membranes.
Dependencies are inferred from the claim text.